gabexate has been researched along with Leukocytosis in 1 studies
Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.
Leukocytosis: A transient increase in the number of leukocytes in a body fluid.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Matsuda, Y | 1 |
| Kawata, S | 1 |
| Nagase, T | 1 |
| Maeda, Y | 1 |
| Yamasaki, E | 1 |
| Kiso, S | 1 |
| Ishiguro, H | 1 |
| Matsuzawa, Y | 1 |
1 trial available for gabexate and Leukocytosis
| Article | Year |
|---|---|
Interleukin-6 in transcatheter arterial embolization for patients with hepatocellular carcinoma. Effects of serine protease inhibitor.
Topics: Aged; Aspartate Aminotransferases; C-Reactive Protein; Carcinoma, Hepatocellular; Chemoembolization, | 1994 |